Back to mobile site

More on EYPT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.9 Score)

Upcoming Events

- Earnings (11/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

EyePoint Pharmaceuticals (NQ:EYPT)
Delayed: 4.58 +0.01 (0.22%)
Prev. Close $4.57  
Open$4.53 
52 Wk High$ 
52 Wk Low$ 
Day High$4.69 
Day Low$4.49 
P/E N/A  
EPS$ 
Volume1,901,890 

Friends, Peers and Foes (?): APLS, RVMD, OCUL, REGN, AMGN (more...)

Sep 2, 2026 02:04 AM TD Cowen Downgrades EyePoint Inc. (EYPT) to Hold
Aug 24, 2026 04:11 PM Form 4 EyePoint, Inc. For: Aug 20 Filed by: Elston George
Aug 18, 2026 04:09 PM Form 4 EyePoint, Inc. For: Aug 18 Filed by: Zaderej Karen L.
Aug 18, 2026 01:27 PM EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
Aug 18, 2026 08:11 AM Chardan Downgrades EyePoint Inc. (EYPT) to Neutral
Aug 18, 2026 06:09 AM H.C. Wainwright Downgrades EyePoint Inc. (EYPT) to Neutral
Aug 18, 2026 02:52 AM RBC Capital Downgrades EyePoint Inc. (EYPT) to Sector Perform
Aug 17, 2026 03:24 PM EyePoint Inc. (EYPT) PT Lowered to $48 at Laidlaw
Aug 17, 2026 01:01 PM Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)
Aug 17, 2026 12:51 PM JPMorgan Downgrades EyePoint Inc. (EYPT) to Neutral
View All Articles

Entities mentioned with EYPT

View All Entities